BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29196913)

  • 1. UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.
    He J; Chen Y; Cai L; Li Z; Guo X
    Breast Cancer; 2018 Mar; 25(2):224-232. PubMed ID: 29196913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of UBA protein 2-like protein inhibits growth and induces apoptosis of human colorectal carcinoma cells.
    Chai R; Yu X; Tu S; Zheng B
    Tumour Biol; 2016 Oct; 37(10):13225-13235. PubMed ID: 27456362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma.
    Li Q; Wang W; Hu YC; Yin TT; He J
    Med Sci Monit; 2018 Oct; 24():7109-7118. PubMed ID: 30291221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ubiquitin associated protein 2-like inhibits the growth and migration of prostate cancer cells.
    Li D; Huang Y
    Oncol Rep; 2014 Oct; 32(4):1578-84. PubMed ID: 25069639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro.
    Zhao B; Zong G; Xie Y; Li J; Wang H; Bian E
    Int J Mol Med; 2015 Oct; 36(4):1012-8. PubMed ID: 26310274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance.
    Wang W; Zhang M; Peng Y; He J
    Med Sci Monit; 2017 Oct; 23():4779-4788. PubMed ID: 28981479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Ubiquitin-associated Protein 2-like in Patients With Uterine Cervical Cancer.
    Yoshida K; Kajiyama H; Inami E; Tamauchi S; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Shibata K; Nawa A; Kikkawa F
    In Vivo; 2020; 34(1):109-116. PubMed ID: 31882469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT; Huang KY; Lin HY; Chung JG
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
    Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
    Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
    Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.
    Wang C; Liang C; Feng W; Xia X; Chen F; Qiao E; Zhang X; Chen D; Ling Z; Yang H
    Int J Mol Med; 2017 Apr; 39(4):1037-1045. PubMed ID: 28290601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
    Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV
    Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1) attributed to disruption of p27(Kip1)/Skp2 complex.
    Hsu JD; Kao SH; Ou TT; Chen YJ; Li YJ; Wang CJ
    J Agric Food Chem; 2011 Mar; 59(5):1996-2003. PubMed ID: 21299246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT-116 cells.
    Jo HJ; Song JD; Kim KM; Cho YH; Kim KH; Park YC
    Oncol Rep; 2008 Jan; 19(1):275-80. PubMed ID: 18097607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norcantharidin-blocked ANXA2P2 inhibits fibroblast proliferation by increasing UBAP2L mRNA stability through LIN28B.
    Huang R; Yang Q; Wang T
    Life Sci; 2021 Aug; 279():119645. PubMed ID: 34043991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.
    Zhu T; Ji Z; Xu C; Peng Z; Gu L; Zhang R; Liu Y
    J Mol Histol; 2014 Dec; 45(6):665-77. PubMed ID: 25027991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
    Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
    Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
    Lin Z; Xiong L; Lin Q
    Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.